Journals / Turkish Journal of Medical Sciences / 2014 / Cilt: 44 - Sayı: 5

Expression and clinical implications of P53, P63, and P73 protein in malignant tumor of the parotid gland

Pages
875–882
Publication Date
2014-05-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our results suggest that the P53, P63, and P73 proteins may play a role in the development of malignant parotid gland tumors and provide data for their diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To investigate the expression of P53, P63, and P73 proteins in malignant parotid gland tumors and adjacent nonneoplastic tissues and the association between the 3 proteins and their clinical characteristics.
📊
Key Findings & Data:Materials and methods: A total of 40 pairs of paraffin-embedded malignant parotid gland tumors and adjacent nonneoplastic tissues were collected.
💡
Conclusion & Impact:Conclusion: Our results suggest that the P53, P63, and P73 proteins may play a role in the development of malignant parotid gland tumors and provide data for their diagnosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:P53/P63/P73 gene · malignant parotid gland tumor · immunohistochemistry

Abstract

To investigate the expression of P53, P63, and P73 proteins in malignant parotid gland tumors and adjacent nonneoplastic tissues and the association between the 3 proteins and their clinical characteristics. Materials and methods: A total of 40 pairs of paraffin-embedded malignant parotid gland tumors and adjacent nonneoplastic tissues were collected. We detected P53, P63, and P73 protein expression by immunohistochemistry. Statistical analysis was performed by using the chi-square test. Results: P53, P63, and P73 protein expression in malignant parotid gland tumors was higher than their expression in adjacent nonneoplastic tissue (P = 0.030, 0.001, and 0.001, respectively). Expression of P53, P63, and P73 proteins was not associated with age, sex, or lymph node metastasis (P > 0.05). Expression of P53 and P73 proteins, instead of the P63 protein, was correlated to the degree of malignancy (P = 0.026 and 0.018, respectively). There was no significant difference among the P53, P73, and P63 proteins in malignant parotid gland tumors (P > 0.05). In the follow-up, only one patient died of colon cancer. Conclusion: Our results suggest that the P53, P63, and P73 proteins may play a role in the development of malignant parotid gland tumors and provide data for their diagnosis.

🔖

Cite This Article

YONG, M., YANG, L., SUYILA, Q., HAN, W., YUAN, H., ZHAO, C., SU, X. (2014). Expression and clinical implications of P53, P63, and P73 protein in malignant tumor of the parotid gland. Turkish Journal of Medical Sciences, Cilt: 44 - Sayı: 5, 875–882. https://ajindex.com/articles/186181

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Wang X. P53 gene and salivary gland tumors. Int J Stomatol 2006; 33: 460–462 (article in Chinese). Renehan AG, Gleave EN, Slevin NJ, McGurk M. Clinico- pathological and treatment-related factors influencing survival in parotid cancer. Br J Cancer 1999; 80: 1296–1300.
  2. Lei AP, Cheng ZG. The clinical analysis of 112 cases of parotid tumors. J Clin Stomatol 2009; 25: 296–297 (article in Chinese). Freed-Pastor WA, Prives C. Mutant p53: one name, many proteins. Genes Dev 2012; 26: 1268–1286.
  3. Tokuchi Y, Hashimoto T, Kobayashi Y, Hayashi M, Nishida K, Hayashi S, Imai K, Nakachi K, Ishikawa Y, Nakagawa K et al. The expression of P73 is increased in lung cancer independent of P53 gene alteration. Br J Cancer 1999; 80: 1623–1629.
  4. Su XL, Ouyang XH, Yan MR, Liu GR. P73 expression and its clinical significance in colorectal cancer. Colorectal Dis 2009; 11: 960–963.
  5. Zhang W, Fu FW, Wang QY. The expression of P73 in human epithelial ovarian carcinoma and its clinical significance. Pract Clin Med 2008; 29: 43–44 (article in Chinese). Zhang J, Chu CJ, Zhang XL, Zhang LY. The expressions and clinical significance of c-erbB-2, p53 and p73 in endometrial cancer. Current Physician 2010; 26: 2–3 (article in Chinese). Yang WG. The expressions and clinical significance of survivn and P73 in breast cancer tissues. J Med Forum 2008; 29: 43–44 (article in Chinese). Liu ML, Li RS, Lin TX, Zhu GJ, Guo SC. A study of the abnormal expressions of P73 in children undergone therapy for acute lymphoblastic leukemia. Chin J Hematol 2002; 23: 239–242 (article in Chinese). Feng SF. The research progress of the correlation between P53 gene mutation and oral neoplasms. Med Recapitulate 2008; 14: 2113–2115 (article in Chinese). Alves FA, Pires FR, De Almeida OP, Lopes MA, Kowalski LP. PCNA, Ki-67 and P53 expressions in submandibular salivary gland tumours. Int J Oral Maxillofac Surg 2004; 33: 593–597.
  6. Tarakji B, Kujan O, Nassani MZ. Immunohistochemical expression of P53 in pleomorphic adenoma and carcinoma ex pleomorphic adenoma. J Cancer Epidemiol 2010; 2010: 250606. Liu W, Chen LL, Liu Y. The expression of P53 protein, vascular endothelial growth factor and microvessel density in salivary gland tumors. J Pract Stomatol 2009; 25: 66–70 (article in Chinese). Liu F, Zhang JZ, Ma M, Han ES, Li GF. Scoring of P53, PCNA in salivary gland adenoid cystic carcinoma and Bd-2 expression and their correlation with the pathological types and recurrence. J Clin Stomatol 2004; 20: 653–655 (article in Chinese).